Association of Genetic Variants With Rivaroxaban Pharmacokinetics and Pharmacodynamics and Hemorrhage Risk Factors in Patients With Venous Thromboembolism. [PDF]
Li H +5 more
europepmc +1 more source
Rivaroxaban in Clinical Practice for Atrial Fibrillation With Special Reference to Prothrombin Time
Shinya Suzuki +14 more
openalex +1 more source
Apixaban- and Rivaroxaban-Associated Bleeding: A Retrospective Analysis Using the FDA Adverse Event Reporting System. [PDF]
Logvinsky IK +5 more
europepmc +1 more source
Retracted: Spontaneous rectus sheath haematoma associated with rivaroxaban treatment
Ayça Taş Tuna +2 more
openalex +1 more source
An Updated Meta-Analysis of Randomized Controlled Trials Comparing Direct Oral Anticoagulants Against Warfarin for Left Ventricular Thrombus Resolution. [PDF]
Magdy J +5 more
europepmc +1 more source
Effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with liver disease: a systematic review and meta-analysis. [PDF]
Zhou Q +7 more
europepmc +1 more source
Involvement of hypoxia-inducible factor1-alpha in the protective effect of rivaroxaban against testicular ischemia-reperfusion in rats. [PDF]
Baset MA +3 more
europepmc +1 more source
Half-dose may be equivalent to full-dose anticoagulants in preventing venous thromboembolism after primary total joint arthroplasty: a single center comparative retrospective cohort study. [PDF]
Wang Y, Liao Z, Zhou Z, Wang H.
europepmc +1 more source
Efficacy and safety of oral anticoagulants in elderly patients with non-valvular atrial fibrillation: a meta-analysis. [PDF]
Fan B, Xia J.
europepmc +1 more source

